High severity · published Aug 22, 2018
CVE-2018-14787
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders…
7.8
CVSS
0.4%
EPSS
No
On KEV
Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
CVSS vector
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack vector
Local
Complexity
Low
Privileges
Low
User interaction
None
Confidentiality
High
Integrity
High
Availability
High
Scope
Unchanged
Exploitation
Is it being used?
Exploit prediction (EPSS)0.4% · higher than 33% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
IC
Intellispace Cardiovascular · Philips
through 3.1 · source: NVD
XC
Xcelera · Philips
through 4.1 · source: NVD
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2018-14787
CVE.org
https://www.cve.org/CVERecord?id=CVE-2018-14787
Third Party Advisory
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
Vendor Advisory
https://www.usa.philips.com/healthcare/about/customer-support/product-security
More from Intellispace Cardiovascular
7.2
CVE-2017-14111
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if…
6.7
CVE-2018-14789
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been…
6.3
CVE-2018-5438
Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user